BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 10507082)

  • 1. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis.
    Biselli R; Boldrini R; Ferlini C; Boglino C; Inserra A; Bosman C
    Pathol Res Pract; 1999; 195(9):619-32. PubMed ID: 10507082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
    Qiu X; Montgomery E; Sun B
    Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. part 2 - tumours and tumour-like lesions.
    Eyden B
    J Submicrosc Cytol Pathol; 2005 Nov; 37(3-4):231-96. PubMed ID: 16612972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast tumors with myofibroblastic differentiation: clinico-pathological observations in myofibroblastoma and myofibrosarcoma.
    Gocht A; Bösmüller HC; Bässler R; Tavassoli FA; Moinfar F; Katenkamp D; Schirrmacher K; Lüders P; Saeger W
    Pathol Res Pract; 1999; 195(1):1-10. PubMed ID: 10048088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory myofibroblastic tumor (inflammatory pseudotumor): DNA flow cytometric analysis of nine pediatric cases.
    Biselli R; Ferlini C; Fattorossi A; Boldrini R; Bosman C
    Cancer; 1996 Feb; 77(4):778-84. PubMed ID: 8616772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.
    Hussong JW; Brown M; Perkins SL; Dehner LP; Coffin CM
    Mod Pathol; 1999 Mar; 12(3):279-86. PubMed ID: 10102613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases.
    Cessna MH; Zhou H; Sanger WG; Perkins SL; Tripp S; Pickering D; Daines C; Coffin CM
    Mod Pathol; 2002 Sep; 15(9):931-8. PubMed ID: 12218210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myofibroblastic tumour (inflammatory pseudotumour) of the breast. Clinicopathological and genetic analysis of a case with evidence for clonality.
    Sastre-Garau X; Couturier J; Derré J; Aurias A; Klijanienko J; Lagacé R
    J Pathol; 2002 Jan; 196(1):97-102. PubMed ID: 11748648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
    Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
    Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA ploidy in salivary gland tumours.
    Driemel O; Maier H; Kraft K; Haase S; Hemmer J
    Oncol Rep; 2005 Jan; 13(1):161-5. PubMed ID: 15583819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory myofibroblastic tumor of the central nervous system and its relationship to inflammatory pseudotumor.
    Swain RS; Tihan T; Horvai AE; Di Vizio D; Loda M; Burger PC; Scheithauer BW; Kim GE
    Hum Pathol; 2008 Mar; 39(3):410-9. PubMed ID: 18261625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometry in the evaluation of the prognosis and course of malignant soft-tissue tumors].
    Zubrikhina GN; Ol'khovskaia IG
    Arkh Patol; 1990; 52(9):29-33. PubMed ID: 2270977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soft tissue myofibroblastomas.
    Herrera GA; Johnson WW; Lockard VG; Walker BL
    Mod Pathol; 1991 Sep; 4(5):571-7. PubMed ID: 1661895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey.
    Coffin CM; Humphrey PA; Dehner LP
    Semin Diagn Pathol; 1998 May; 15(2):85-101. PubMed ID: 9606801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade abdominopelvic sarcoma with myofibroblastic features (low-grade myofibroblastic sarcoma): clinicopathological, immunohistochemical, molecular genetic and ultrastructural study of two cases with literature review.
    Agaimy A; Wünsch PH; Schroeder J; Gaumann A; Dietmaier W; Hartmann A; Hofstaedter F; Mentzel T
    J Clin Pathol; 2008 Mar; 61(3):301-6. PubMed ID: 17513510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory fibrosarcoma: update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors.
    Meis-Kindblom JM; Kjellström C; Kindblom LG
    Semin Diagn Pathol; 1998 May; 15(2):133-43. PubMed ID: 9606804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcifying fibrous pseudotumor versus inflammatory myofibroblastic tumor: a histological and immunohistochemical comparison.
    Hill KA; Gonzalez-Crussi F; Chou PM
    Mod Pathol; 2001 Aug; 14(8):784-90. PubMed ID: 11504838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.
    Coffin CM; Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Apr; 31(4):509-20. PubMed ID: 17414097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.